ARCH Venture Fund IX Overage, L.P.'s Net Worth
$0
Who is ARCH Venture Fund IX Overage, L.P.?
ARCH Venture Fund IX Overage, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Lyell Immunopharma, Inc., Gossamer Bio, Inc., Karuna Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., and Boundless Bio, Inc..
SEC CIK
ARCH Venture Fund IX Overage, L.P.'s CIK is 0001666307
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 36.41M |
—
|
—
| 36.41M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.06M |
—
|
—
| 8.06M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karuna Therapeutics, Inc. (KRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.85% | -148.74K |
—
|
—
| 2.92M |
Apr 13
| |||
Form 4
| -4.63% | -148.74K |
—
|
—
| 3.07M |
Jan 8
| |||
Form 4
| -4.42% | -148.74K |
—
|
—
| 3.21M |
Nov 12
| |||
Form 4
| +364.09% | 3.36M |
$16.00 | $1,600,000.00 | 4.29M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.44% | -964.98K |
—
|
—
| 27.09M |
Sep 2 - Sep 6
| |||
Form 4
| -3.22% | -964.99K |
—
|
—
| 28.98M |
Aug 30 - Aug 31
| |||
Form 4
| -3.03% | -964.99K |
—
|
—
| 30.91M |
Aug 24 - Aug 25
| |||
Form 4
| -2.90% | -482.50K |
—
|
—
| 16.18M |
Aug 18
| |||
Form 4
| -2.74% | -1.45M |
—
|
—
| 51.42M |
Aug 12 - Aug 16
| |||
Form 4
| -2.60% | -482.50K |
—
|
—
| 18.11M |
Jun 8
| |||
Form 4
| -2.53% | -482.50K |
—
|
—
| 18.59M |
Jun 2
| |||
Form 4
| -8.13% | -1.69M |
—
|
—
| 19.07M |
Dec 20
| |||
Form 4
| -2.27% | -482.51K |
—
|
—
| 20.76M |
Nov 29
| |||
Form 4
| -2.22% | -482.51K |
—
|
—
| 21.24M |
Nov 22
| |||
Form 4
| -15.44% | -3.97M |
—
|
—
| 21.73M |
Jul 1
| |||
Form 4
| -3.72% | -991.65K |
—
|
—
| 25.69M |
Jun 22
| |||
Form 4
| -1.81% | -991.64K |
—
|
—
| 53.86M |
Apr 7 - Apr 8
| |||
Form 4
| -1.74% | -991.65K |
—
|
—
| 55.85M |
Mar 30 - Apr 1
| |||
Form 4
| +6,350.01% | 28.22M |
$20.00 | $20,000,000.00 | 28.67M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Beam Therapeutics Inc. (BEAM) Snapshot price: $23.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.24% | -391.95K |
—
|
—
| 5.89M |
Jun 30
| |||
Form 4
| -7.52% | -783.90K |
—
|
—
| 9.64M |
Jun 25 - Jun 29
| |||
Form 4
| -5.32% | -396.63K |
—
|
—
| 7.05M |
Mar 31
| |||
Form 4
| -6.52% | -793.27K |
—
|
—
| 11.37M |
Mar 18 - Mar 22
| |||
Form 4
|
∞
| 8.24M |
—
|
—
| 8.24M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||